ISTH Academy

Create Account Sign In
New Insights in Diagnosis and Treatment of Antiphospholipid Syndrome
  • 14:00 - 15:00 UTC
  • 10:00 - 11:00 ET (US & Canada)
  • 16:00 - 17:00 CEST (Central Europe)
  • 22:00 - 23: 00 HKT (SIngapore & Hong Kong)

This live session will be hosted on:
July 31, 2024 14:00-15:00 UTC

Session Description
This webinar will feature talks by Dr. Mary-Carmen Amigo and Dr. Scott Woller discussing new insight in diagnosis and treatment of antiphospholipid syndrome.

Event Outline:

  • Introduction by Anna Parks, M.D.
  • 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria by Mary-Carmen Amigo, M.D. (20 minutes)
  • Is there a role for direct oral anticoagulants in the treatment of antiphospholipid syndrome? by Scott Woller, M.D. (20 minutes)
  • Q&A with audience (15 minutes)

Learning Objectives

2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria 

  • Differentiate between classification and diagnostic criteria
  • Discuss how to accurately interpret the 2023 ACR/EULAR APS Classification criteria for research purposes
  • Consider classification criteria are not for diagnosis and treatment in daily practice

Is there a role for direct oral anticoagulants in the treatment of antiphospholipid syndrome? 

  • Understand the historical role of anticoagulation and thrombotic APS
  • Review clinical trials that assessed the comparative safety and effectiveness of DOACs with BKA for the treatment of thrombotic APS
  • Discuss how to interpret results and effectiveness of DOACs with BKA for the treatment of thrombotic APS
  • Understand cliinical guidance surrounding best practice for the treatment of thrombotic APS

Supported by Werfen

 

Faculty

Anna Parks, M.D.
University of Utah
Division of Hematology
Salt Lake City, Utah
United States

Mary-Carmen Amigo, M.D.
The ABC Medical Center
Mexico City, Mexico

Scott Woller, M.D.
Intermountain Medical Center
Murray, Utah
United States

Fibrin Formation and Fibrinolysis Testing in Research
  • 14:00 - 15:00 UTC
  • 10:00 - 11:00 ET (US & Canada)
  • 16:00 - 17:00 CEST (Central Europe)
  • 22:00 - 23:00 HKT (Singapore & Hong Kong)

Session Description
This webinar will feature talks by Dr. Fraser Macrae and Dr. Valerie Tutwiler discussing fibrin formation and fibrinolysis testing in research.

Event Outline:

  • Introduction by Tirsa van Duijl, Ph.D.
  • Microscopy approaches to study fibrin by Fraser Macrae, Ph.D. (20 minutes)
  • In vitro assays to study fibrin formation and FXIII crosslinking by Valerie Tutwiler, Ph.D. (20 minutes)
  • Q&A with audience (15 minutes)

Learning Objectives

Microscopy Approaches to Study Fibrin

  • Understand why we study changes in fibrin clot structure
  • Understand how multiple microscopy methods can be used to investigate fibrin clot structure

In vitro assays to study fibrin formation and FXIII crosslinking

  • Review techniques that can be utilized to assess dynamic changes in clo formation/dissolution
  • Determine the best technique for looking at changes in clotting kinetics and structure
Faculty

Tirsa van Duijl, Ph.D.
Sanquin Research
Amsterdam, North Holland
Netherlands

Fraser Macrae, Ph.D.
LIGHT Labs, Clarendon Way
Leeds, England
United Kingdom

Valerie Tutwiler, Ph.D.
Rutgers University
Piscataway, New Jersey
United States

Upon completion of this activity, participants should be able to:
  • Describe cardinal features in the presentation of TTP
  • Distinguish between TTP and other disorders of thrombocytopenia
  • Identify appropriate clinical steps for patients with suspected TTP

Activity Title: A Hematologic Emergency: Would You Miss iTTP?
Topic: immune-mediated thrombotic thrombocytopenic purpura (aTTP/iTTP)
Accreditation Type: Physicians—Maximum of 1.0 AMA PRA Category 1 Credit(s)™
Nurses—1.0 contact hours of nursing continuing professional development credit
PAs—maximum of 1.0 AAPA Category 1 CME credits 
Release Date: August 4, 2023
Expiration Date: August 3, 2024
Estimated Time to Complete Activity: 1.0 hour

METHOD OF PARTICIPATION/HOW TO RECEIVE CREDIT

There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, completing the activity, and completing the post-test and evaluation form. A score of at least 75% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.

Credit fulfillment:
If you are requesting AMA credits, ANCC credits, or a certificate of participation, your certificate will be available for download.

Technical Requirements
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox, and Safari browsers.

Additionally, this site and its activities are best viewed using the latest operating system for your device.

 

TARGET AUDIENCE
This educational activity is intended for physicians and advanced practice professionals (APPs), including nurse practitioners and PAs who specialize in hematology, emergency medicine, critical care, nephrology, neurology, obstetrics, primary care, and other specialties who treat patients with hematologic emergencies.

PROGRAM OVERVIEW
This activity is designed to provide clinicians with education on how to recognize and diagnose iTTP and provide education on the management of acute episodes of iTTP, including the risk of relapse and strategies for multidisciplinary management with clinical colleagues.

DISCLAIMER
The France Foundation and ISTH present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, ISTH, and the commercial supporter(s) assume no liability for the information herein.

Faculty

Spero Cataland, MD
Professor of Internal Medicine
Division of Hematology
Ohio State University
Columbus, OH

Nathan Nielsen, MD, MSc, FCCM
Associate Professor
Division of Pulmonary Critical Care and Sleep Medicine
University of New Mexico School of Medicine
Albuquerque, NM

Marie Ann Scully, MBE, BSc (Hons), MBBS, MRCP, FRCPath
Professor of Hemostasis and Thrombosis
Department of Hematology
University College London Hospitals
London, UK

We found no results for your search. Please change or remove at least one filter to broaden your search.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies